Curevac N.V. (NQ: CVAC )
3.010
+0.050
(+1.69%)
Streaming Delayed Price
Updated: 11:34 AM EDT, Oct 4, 2024
Add to My Watchlist
All News about Curevac N.V.
CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
March 30, 2022
From CureVac
Via AccessWire
Exposures
COVID-19
From CureVac
Via AccessWire
From CureVac
Via AccessWire
CureVac (CVAC) Q3 2021 Earnings Call Transcript
November 19, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
CureVac's COVID-19 Vax Shows Comparable Antibody Levels To Pfizer/BioNTech's Shot In Animal Study
November 18, 2021
Via Benzinga
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|